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Abstract
A major task in dissecting the genetics of complex traits is to identify causal genes for disease 
phenotypes. We previously developed a method to infer causal relationships among genes through 
the integration of DNA variation, gene transcription, and phenotypic information. Here we 
validated our method through the characterization of transgenic and knockout mouse models of 
candidate genes that were predicted to be causal for abdominal obesity. Perturbation of eight out 
of the nine genes, with Gas7, Me1 and Gpx3 being novel, resulted in significant changes in obesity 
related traits. Liver expression signatures revealed alterations in common metabolic pathways and 
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networks contributing to abdominal obesity and overlapped with a macrophage-enriched 
metabolic network module that is highly associated with metabolic traits in mice and humans. 
Integration of gene expression in the design and analysis of traditional F2 intercross studies allows 
high confidence prediction of causal genes and identification of involved pathways and networks.
The discovery of novel genes which contribute to complex human disorders remains a 
challenge for geneticists. The conventional methodology of determining whether a particular 
locus is involved in a given disease involves testing for inheritance of specific genomic 
regions in successive generations of affected individuals. This typically leads to multiple 
loci (known as quantitative trait loci, or QTLs), each of which contributes modestly to the 
overall phenotype. Each locus may contain hundreds of genes, making the elucidation of the 
underlying gene or genes labor intensive and time consuming. Additionally, differentiating 
genes that are causal for the disease from those that are reactive to the biological alterations 
resulting from the disease has been difficult.
The advent of microarray technology has enabled scientists to simultaneously examine 
alterations in the mRNA levels of thousands of transcripts in a sample. Since microarrays 
yield quantitative estimates of gene expression changes, the loci that control their expression 
can be mapped. These loci are known as expression QTLs (or eQTLs). eQTLs that map near 
the gene and are likely to regulate gene expression in cis are termed cis-eQTLs 1. Genes 
with cis-eQTLs that are coincident with a clinical disease-related trait QTL (or cQTL) have 
an increased likelihood of contributing causally to the particular disorder, especially if 
expression of the gene is correlated with the severity of the disease trait 2,3.
However, correlation between an expression trait and a clinical phenotype does not imply a 
causal/reactive relationship due to linked causal mutations, and particular alleles may also 
influence RNA levels and phenotypes independently, further confounding the analysis. 
There is unambiguous biological directionality in that DNA changes influence alterations in 
transcript abundances and clinical phenotypes, so the number of possible relationships 
among correlated traits can be greatly reduced. For example, among two traits which are 
correlated and controlled by a unique DNA locus, only three likely relationship models 
exist, namely causal, reactive, and independent 4,5. Therefore, after constructing a network, 
one can simultaneously integrate all possible DNA variants and their underlying changes in 
transcript levels, and each relationship can be supported as being causal, reactive, or 
independent in relation to a particular phenotype such as obesity. This is referred to as the 
likelihood-based causality model selection (LCMS) procedure 4.
Using our LCMS procedure, we have predicted ~100 causal genes for abdominal obesity 
using an F2 intercross between the C57BL/6J and DBA/2J strains of mice (the BXD cross) 
4. In order to validate the predictive power of LCMS, we carried out phenotypic 
characterization of transgenic or knockout mouse models for nine of the top candidate 
genes, and report here that in total eight out of the nine genes under characterization were 
found to influence obesity-related traits. We analyzed liver gene expression signatures of the 
transgenic and knockout mouse models and demonstrated that all nine genes affect common 
pathways and subnetworks that relate to metabolic pathways, suggesting that obesity is 
driven by a gene network instead of a single gene.
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RESULTS
Knockout (ko) or transgenic (tg) mouse models for the nine candidate causal genes were 
constructed or obtained from vendors or institutional investigators 6–8 (Supplementary 
Table 1). Except for Gas7 as noted below, transgene expression patterns were similar to 
those of the endogenous genes 4,7 (Supplementary Fig. 1). We previously demonstrated a 
preliminary validation of Zfp90, C3ar1, Tgfbr2, Lactb, and Lpl in modifying adiposity using 
ko or tg mice 4,9. Here we present additional validation evidence from these mouse models, 
and the obesity-related phenotypic characteristics, gene expression signatures, and pathway/
network analyses of four additional candidate causal genes: Gas7 (tg), Gpx3 (tg), Gyk (ko), 
and Me1 (ko).
In vivo characterization of mouse models
We previously showed that Zfp90 tg mice had a significantly increased fat mass to lean mass 
ratio 4. Additional phenotyping indicated that Zfp90 tg mice also had significantly increased 
body weight, total fat pad mass, adiposity, and retroperitoneal, mesenteric, and subcutaneous 
fat pad masses (Supplementary Table 2) compared to wt mice. Plasma lipid profiles showed 
non-significant trends for LDL and other parameters (Supplementary Table 3), but our 
ability to assess these was limited since Zfp90 tg mice were unable to breed and only three tg 
founders were studied.
As described previously, male C3ar1 ko and male Tgfbr2 heterozygous ko mice (Tgfbr2 
homozygous ko animals are not viable) had reduced fat/lean ratio as compared to their wild-
type (wt) littermates 4. Analysis of additional mice from both sexes confirmed our previous 
results (Supplementary Table 2; Figure 1a–1d). Interestingly, female C3ar1 ko and female 
Tgfbr2 heterozygous mice demonstrated opposing trends (Figure 1b and 1d compared to 1a 
and 1c). Individual fat pad masses were not significantly different between Tgfbr2 
heterozygotes and wt, although males and females retained the opposite trends 
(Supplementary Table 2). Similarly, male and female C3ar1 ko mice retained the opposite 
trends in individual fat pad masses, (Supplementary Table 2), suggesting the existence of a 
sex-by-genotype interaction for C3ar1 and Tgfbr2. Female Tgfbr2 heterozygous ko also 
exhibited a significant increase in endpoint free fatty acids, but no significant alterations 
were seen in endpoint lipid levels for C3ar1 ko (Supplementary Table 3).
Heterozygous Lpl ko mice were previously shown to have increased adiposity 9. Male but 
not female heterozygotes also had significantly increased fat pad weights compared to 
controls (Supplementary Table 2). Both male and female heterozygous mice had 
significantly increased endpoint triglycerides. Females also exhibited increased unesterified 
and total cholesterol levels (Supplementary Table 3).
The increased adiposity of Lactb tg mice noted previously 9 was confirmed in an additional 
Lactb tg line in female mice, but not in males (Supplementary Figs. 2a and 2b). Neither male 
nor female tg mice showed alterations in individual fat pad weights or lipid levels 
(Supplementary Tables 2 and 3).
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Gas7 tg mice were constructed as described in the Methods. Expression of the human 
transgene was found in all tissues analyzed except for the spleen, while the endogenous 
mouse Gas7 was only expressed significantly in the brain (Supplementary Fig. 1b). Male but 
not female Gas7 tg mice showed significantly decreased fat/lean ratio as compared to wt 
littermates (Figure 1e and 1f), which were confirmed in an additional independent Gas7 tg 
line (Supplementary Figs. 2c and 2d). Male Gas7 tg also had significantly decreased body 
weight, gonadal fat pad weight, and total fat pad weight, and females had significantly 
decreased mesenteric fat pad weight (Supplementary Table 2). Moreover, male Gas7 tg 
showed significantly reduced triglycerides, unesterified cholesterol, and glucose levels and 
significantly increased endpoint total cholesterol and HDL levels, while female tg mice 
showed only significantly reduced unesterified cholesterol levels (Supplementary Table 3).
For Gas7 tg males, the difference in adiposity appeared at the first measurement time point 
at 11 weeks of age and the increase in the difference with age was not as obvious as in the 
other models. To assess a possible embryonic effect of the tg, we measured body weights of 
male Gas7 mice at weaning (3 weeks) and found that these were not significantly different 
than littermate controls for both transgenic lines. The body weights at weaning from the 
Gas7 transgenic line analyzed in Figure 1e are presented as Supplementary Figure 2e.
Gpx3 male but not female tg mice showed a significant decrease in fat/lean ratio growth 
compared to controls (Figures 1g and 1h). No differences in individual fat pad weights were 
seen (Supplementary Table 2). Female Gpx3 tg mice showed increased endpoint total 
cholesterol and HDL levels as compared to female controls (Supplementary Table 3).
Gyk is located on the X chromosome, and knockout males die by 4 days of life, while 
homozygous females are likely embryonic lethal 8. Therefore, only Gyk female 
heterozygous mice were characterized. There were no significant alterations in fat/lean ratio 
as compared to their wt littermates (Supplementary Fig. 2f), nor in individual or total fat pad 
weights (Supplementary Table 2). They did, however, exhibit decreases in free fatty acids 
and glucose levels (Supplementary Table 3).
The Me1 ko mice were characterized at a separate facility where the growth curves of body 
weight instead of adiposity were recorded while mice were on several different diets 
including a medium high fat diet (44.9% Kcal from fat) and a high sucrose diet (76.5% kcal 
from carbohydrate). Both male and female Me1 ko mice on a medium high fat diet 
demonstrated decreased body weight (Figure 1i and 1j). A similar trend was also observed in 
male though not female ko mice on a high sucrose diet (Supplementary Figs. 2g and 2h). We 
measured adiposity by NMR at the beginning and the end of the diet period in the Me1 mice 
fed on high fat and high sucrose diets and did not find significant differences in initial or 
endpoint adiposity in mice on either diet (Supplementary Figs. 2i and 2j), though there was a 
trend of reduced endpoint fat mass as determined by NMR in male ko mice on high sucrose 
diet (7.61 ± 0.31 in ko and 6.75 ± 0.26 in wt; p=0.06), consistent with the decreased body 
weight. Me1 ko mice on high fat but not a high sucrose diet showed a significant difference 
in food intake (males only) relative to littermate controls (Supplemental Figure 3). Thus, 
food intake alone cannot account for the significantly decreased body weight in Me1 ko 
mice.
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Gene expression profiling of mouse models
In order to explore the mechanisms underlying the observed phenotypic changes, we 
profiled male liver tissue from each mouse model (with the exception of the Gyk female ko) 
to obtain gene expression signatures for each of the individual candidate causal genes. As 
shown in Table 1, at p<0.05 (t test), we observed hundreds to thousands of genes whose 
expression levels were altered in the livers of each of the tg or ko mouse strains compared to 
their wt littermate mice. The false discovery rate (FDR) ranged from 1.9%–86% at this p-
value cutoff. The high FDR values in most of the profiling experiments are likely due to the 
relatively small number of mice (n=3 to 9) involved. The signature genes can be found in 
Supplementary Tables 4–12. We reasoned that although the relatively high levels of FDR 
would influence the confidence in individual signature genes identified, they should have 
less impact on the pathway analyses discussed below.
Two complementary methods, including Fisher's exact test-based enrichment analysis of the 
Gene Ontology (GO) functional categories 10, Panther pathways 11, or Ingenuity canonical 
pathways (Ingenuity® Systems, www.ingenuity.com), and Gene Set Enrichment Analysis 
(GSEA) of curated functional gene sets from public databases based on weighted 
Kolmogorov–Smirnov-like statistics 12 were used to analyze the functional relevance of the 
liver gene expression profiles to the phenotypic traits.
The liver gene signatures from these mouse models are enriched for many overlapping 
metabolic pathways (Table 1; Supplementary Table 13). Multiple mouse models showed 
enrichments for pathways related to steroid, fatty acid, amino acid, and glutathione 
metabolism pathways, as well as purine metabolism, the pentose phosphate pathway, and 
IL-10 signaling. Previously, we reported 13 TCA cycle-centered metabolic pathways as 
being differentially affected in fat and lean mice from the F2 DBA/J and C57BL/6J 
intercross 13. As depicted in Figure 2, two or more over-represented metabolic pathways 
identified for each strain of mice in the current study overlapped with these previously 
described pathways. Therefore, the causal genes identified by the LCMS procedure and 
tested in this study likely affect adiposity by modifying similar obesity-related pathways. 
Moreover, as shown in Table 2, the signature genes from each of the mouse models overlap 
significantly with the signature genes identified from one or more of the other mouse 
models.
Overlap between liver signature genes from mouse models and a macrophage-enriched 
metabolic network (MEMN)
Based on the co-expression networks constructed from liver and adipose tissues collected 
from a mouse cross between C57BL/6J (B6) and C3H/HeJ on an apolipoprotein E null 
background (BXH/apoE), we previously identified a macrophage-enriched metabolic 
network (MEMN) that is highly associated with metabolic traits and appears to be of 
macrophage-derived origin 9. Five of the nine genes under validation, namely, Zfp90, Lactb, 
Lpl, C3ar1, and Tgfbr2, are within this MEMN subnetwork. In addition, the liver gene 
signatures derived from five out of the nine validation mouse models, Zfp90 tg, Gpx3 tg, Lpl 
ko, C3ar1 ko, and Tgfbr2 ko, significantly overlapped with MEMN genes (Table 2). Recall 
that these candidate genes were identified as causal genes for obesity from a C57BL/6 × 
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DBA/2J cross. Now, in a different mouse cross setting (BxH/apoE), many of these candidate 
genes and their downstream genes are confirmed to be within or highly overlap with a 
coexpression subnetwork that is relevant to obesity, diabetes, and atherosclerosis traits. 
Furthermore, we recently uncovered a human MEMN which is associated with obesity-
related traits and contains extensive overlap with the mouse MEMN we describe here 14. 
Therefore, it is not surprising to find C3AR1, LACTB, and LPL as well as the previously 
characterized HSD11B1 15 among the human MEMN network genes, further highlighting 
the shared networks between mice and humans and suggesting a common mechanism 
leading to the development of obesity.
Bayesian network analysis of liver signatures in mouse models
As the sample sizes for defining perturbation signatures were small, the quality of the 
signatures derived could be noisy, thus limiting our ability to see additional significant 
overlaps between these signatures. To overcome the problem of noisy signatures, we 
projected them onto our liver transcriptional Bayesian network and then compared the 
subnetworks around the signatures instead of signatures themselves 16.
We previously described a method to reconstruct probabilistic, causal Bayesian networks by 
integrating genetic and gene expression data 4,17. A liver transcriptional network was 
constructed based on three F2 intercross populations derived from the C57BL/6J, C3H/HeJ, 
and CAST/Ei strains described previously 18 (see Methods). For each perturbation 
signature, we extracted the largest connected subnetwork in the whole liver transcriptional 
network as described 19 (see Methods). All of these subnetworks overlapped significantly 
with one another and with the MEMN module (Table 3), again suggesting that all causal 
genes affect a common pathway.
A core subnetwork consisting of 637 genes (Figure 3; Supplementary Table 14) was 
identified to be common in at least five of the nine perturbation signature subnetworks, 
while there was no gene that was common in at least five of the nine perturbation signatures 
themselves. Genes in this core subnetwork were significantly enriched in many GO 
biological processes (Table 4), and also significantly overlapped with the coexpression 
module MEMN described above. The core subnetwork consisted of Zfp90, Lactb, and well 
known key regulators for fatty acid and lipid metabolism Insig1 and Insig2 20,21, and many 
classic cholesterol and fatty acid metabolic genes such as Hmgcs1, Sqle, Dhcr7, and Fasn. 
This suggests that the possible mechanism of the nine candidate causal genes giving rise to 
the obesity phenotype is through perturbations of this core subnetwork.
Relationship to human genome-wide association findings
Recent genome-wide association studies (GWAS) have identified more than ten loci that are 
associated with obesity-related traits 22–28. These loci include the highly replicated ones 
such as FTO and MC4R as well as the less replicated ones such as INSIG2, GNPDA2, 
TMEM18, NEGR1, and SH2B1. Although none of the nine causal genes that we have tested 
are within the obesity GWAS findings, the obesity GWAS gene INSIG2 is within the core 
subnetwork that we identified, and LPL has been associated with triglyceride and HDL traits 
in GWAS 29,30.
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One way to link our study to human GWAS is to test whether the causal genes we identified 
in mouse are enriched for harboring variations in human populations that show evidence of 
association (for example, low p values that may not reach the stringent threshold required 
for genome-wide significance) with obesity traits. Utilizing data from the Broad Institute 
GWAS control population 31, we tested the 667 core subnetwork genes for enrichment of 
neighboring SNPs (termed cis-SNPs) with low body mass index (BMI) association p values 
(see Methods for details). We did not find any enrichment for cis-SNPs with low association 
p values to BMI among the genes composing the full core sub-network set. However, when 
the 102 mouse MEMN genes within the core sub-network were considered, we did observe 
a significant enrichment for SNPs with low association p values to BMI.
Specifically, 12.5% (267 out of 2132) of cis-SNPs selected from the 102 mouse MEMN 
genes in the core subnetwork reached an BMI association cutoff of p<0.1, as compared to an 
average of 10.4% [95% confidence interval (CI): 7.9% to 12.6%] in the cis-SNPs derived 
from 105 sets of randomly selected 102 genes by permutation. The enrichment p value was 
0.031, defined as the probability of obtaining the observed result or even more extreme 
under random sampling. In addition, the average log of association p values (logP) for the 
cis-SNPs of the 102 mouse MEMN core subnetwork genes is −1.11, as compared to an 
average of −1.00 [95% CI: −1.10 to − 0.91] in the 105 random sets (p=0.010). The 
comparison of the percentage of low association p values and the average logP between the 
mouse MEMN core subnetwork genes and the 105 random gene sets are shown in 
Supplementary Figures 4a and 4b, respectively.
DISCUSSION
As summarized in Table 5, genetic perturbation of eight out of the nine (~90%) candidate 
genes which were predicted to be causal for obesity in mice using our LCMS procedure 
caused significant alterations in fat/muscle ratios as well as relevant changes in body weight, 
adiposity (total fat/body weight), individual fat pad masses or plasma lipids. Furthermore, 
we identified corresponding changes in the liver expression of genes involved in metabolic 
pathways previously identified to be differentially regulated between fat and lean mice 13. 
Therefore, a large majority of the candidate causal genes for abdominal obesity predicted by 
LCMS were validated at both a phenotypic and a gene expression level. The liver gene 
expression signature genes from the validation mouse models highly overlapped with one 
another and with the metabolic trait-associated MEMN module genes. All of these causal 
candidate genes were found to impact a common liver transcriptional subnetwork that is 
enriched for GO metabolic pathways and the MEMN module. These multiple lines of 
evidence suggest that the perturbation of these predicted causal genes influences obesity via 
a common functional mechanism.
Interestingly, sex specificity in phenotypic effect was common, and we observed opposing 
effects on abdominal obesity between the sexes in C3ar1 ko and Tgfbr2 heterozygous ko 
mice. Sex hormones can affect Tgfbr2 expression 32, and C3a stimulates the release of 
ACTH, which is involved in the production of androgens 33. Down-regulation of both genes 
in the ko mouse models may alter the impact of sex hormones and lead to sex-specific 
phenotypes.
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Among the newly validated genes, Gas7 was originally identified as a gene that was 
expressed in serum-starved NIH3T3 cells, and its protein structure resembles Oct2 and 
synapsins, which are involved in neuronal development and neurotransmitter release, 
respectively 34,35. It is selectively expressed in mature cerebral cortical, hippocampal, and 
cerebellar neurons 35. Our studies now indicate relevance of this gene to fat metabolism and 
other previously unknown pathways such as the insulin signaling pathway.
Gpx3 is involved in cellular protection against oxidative damage through the reduction of 
peroxides 36. The cytosolic isoform of Gpx3, Gpx1, has been associated with obesity 37, 
and recently the dysregulation of Gpx3 in the plasma and adipose of obese subjects has been 
implicated in the increase in inflammatory signals and oxidative stress and hence obesity-
related metabolic disorders 38. Our study provides primary evidence that Gpx3 is a causal 
gene for obesity and supports that Gpx3 overexpression modifies insulin resistance 38. 
Although the magnitude of the effect of Gpx3 tg on phenotype was relatively weak (Figure 
1g and 1h), the liver gene expression signature from the Gpx3 animals highly overlaps that 
of Gas7, Lactb, Gyk, and Lpl as well as significantly overlaps the MEMN genes (Table 2), 
suggesting that Gpx3 is causally affecting abdominal obesity along with the other genes 
validated in our study. The weak phenotypic validation might be a result of low copy 
number of the transgene 7 and susceptibility to compensatory mechanisms in gene networks 
9.
Me1 encodes a cytosolic NADP(+)-dependent enzyme involved in the regeneration of 
pyruvate from malate back to the mitochondria, forming a link between the glycolytic 
pathway and the citric acid cycle 39. By assisting with the release of acetyl-CoA and 
NADPH from the mitochondria into the cytosol, they are made available for de novo fatty 
acid biosynthesis and other metabolic processes. Me1 is considered lipogenic and altered 
levels of Me1 enzyme activity has been associated with obesity mouse and rat models 40,41. 
Recently, Me1 was identified as a primary candidate gene underlying a porcine QTL 
associated with backfat thickness 42.
Gyk encodes an enzyme responsible for the metabolism of endogenous and dietary 
glycerolipids 8. Deficiency in Gyk has been linked to altered fat and lipid metabolism 8,43, 
and deficiency in Aqp7 which elevates Gyk expression has been associated with obesity 
development 44. In this study, we did not validate this gene at the phenotypic level. 
However, pathway analysis of the liver Gyk signature indicated that 5 out of 13 of the 
metabolic pathways previously linked to fat content were affected, and the Gyk 
heterozygous ko liver signature highly overlapped with the signatures derived from mouse 
models of other validated genes including Gas7, Gpx3, Lactb, and Me1, supporting a causal 
role. The lack of phenotypic validation might be a result of insufficient perturbation 
represented by the heterozygous ko.
When directly comparing our causal genes with the findings from the recent human GWAS 
studies, we only found limited overlaps. We reason that the GWAS genes/loci represent the 
cis variations in human population that confer disease risk, whereas by requiring multiple 
overlapping loci between the expression and fat mass traits in our LCMS method we 
implicitly required the causal genes to be affected in trans by a given genetic locus and then 
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cause variations in the obesity traits. Thus, it is not surprising to observe a limited overlap 
between the GWAS genes and the mouse causal genes we have identified. The causal genes 
that are affected by DNA variation in trans may not have been identified in the GWAS 
because the signals were too subtle to detect with the current scale, yet are still of interest 
because they are supported as causal. The fact that we found a weak enrichment for SNPs 
with low association p values to BMI from the Broad Institute GWAS population 31 when 
the mouse MEMN genes within the core subnetwork were considered supports this 
hypothesis.
In summary, we have validated the majority of the top genes predicted to be causal for 
abdominal obesity through phenotypic characterization and gene expression profiling, thus 
supporting the LCMS as a powerful tool in predicting causal genes for diseases. Although 
the genes are seemingly disparate, each appears to affect metabolic pathways that are linked 
to the TCA cycle. Future directions include the application of these network approaches to 
additional relevant tissues such as adipose, with incorporation of potential cross-tissue 
interactions, as well as environmental variations. Also, the investigation of negative 
predictive value of the LCMS procedure would be of value, though this is a more 
complicated problem than it appears on the surface, given that a list of LCMS predicted 
causal genes from one tissue is by no means comprehensive as many tissues are involved in 
the regulation of body fat. Considering that a large number of genes influence body weight, 
focusing on pathways and networks rather than pinpointing individual genes may be more 
efficient in elucidating the pathogenesis of obesity and the development of novel treatments.
METHODS
Construction of mouse models
Details regarding the Gas7 transgenic and Me1 knockout mouse models can be found in the 
Supplementary Methods. The Zfp90, Lactb, and Gpx3 transgenic and Gyk and Lpl knockout 
mouse models were constructed as described previously 4,6–8. Tgfbr2 and C3ar1 knockout 
mouse models were obtained from Deltagen as described previously 4.
Breeding and genotyping of mice
All mice except Me1 mice were bred at UCLA and were fed a 4% chow diet (Harlan Teklad 
7017; 4% fat, 0% cholesterol) ad libidum and maintained on a 12 hour light/dark cycle. 
Genomic DNA was isolated from ear and tail samples using a DNeasy kit (Qiagen, CA) and 
genotyped using PCR. All reactions were carried out using initial enzyme activation at 95°C 
for 5 minutes, followed by 35 cycles at 95°C for 30 seconds, 56°C for 30 seconds, and 72°C 
for 1 minute, and finished with an extension at 72°C for 7 minutes. A detailed method for 
breeding and genotyping Me1−/− mice has been described by Qian et al 41.
Phenotypic characterization of the mouse models
Starting at 11 weeks of age, mice (except Me1 ko) were fed a 6% chow diet (Harlan Teklad 
7013; 6.25% fat, 0% cholesterol) for 12 weeks. Each mouse was monitored for body weight 
and evaluated by NMR (Brucker Minispec) for body weight composition including lean 
mass, fat mass and water content over the course of the diet every two weeks. At the end of 
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the 12-week diet, mice were sacrificed using CO2 asphyxiation. Gonadal (fat surrounding 
the gonads), retroperitoneal (fat beneath the kidneys), mesenteric (fat attached to the 
intestines), and subcutaneous (fat below the surface of the skin on the thighs) fat pads were 
collected and weighed. Liver was collected for RNA profiling. All procedures were done in 
accordance with the current National Research Council Guide for the Care and Use of 
Laboratory Animals and were approved by the UCLA Animal Research Committee. 
Additional details regarding the characterization of the Gpx3 and Me1 mice can be found in 
the Supplementary Methods.
Analysis of phenotypic data
The Student’s t-test was used to analyze the differences in the phenotypic traits between tg 
or ko animals and their wt littermate controls. The significance level was set to p<0.05. 
Significance of the difference in the growth curves of fat/muscle ratio between tg/ko and wt 
controls for all mouse models except Me1 ko mice and in growth curves of body weight for 
Me1 mice was determined using an autoregressive method described previously to enhance 
the power of difference detection by leveraging multiple repeated measures over a number 
of time points for each animal 4.
RNA sample preparation and microarray processing
For the liver tissues from the Zfp90 transgenics, the Tgfbr2 heterozygous ko, the C3ar1 ko, 
the Lpl heterozygous ko, the Me1 ko, and each of their respective littermate control mice, 
RNA preparation and array hybridizations were performed at Rosetta Informatics. For 
C3ar1, Tgfbr2 and Zfp90 mouse strains, the custom ink-jet microarrays used in this study 
were manufactured by Agilent Technologies (Palo Alto, CA) and consisted of 23,574 non-
control oligonucleotides extracted from mouse Unigene clusters and combined with RefSeq 
sequences and RIKEN full-length cDNA clones. For Lpl and Me1 mouse strains, the Agilent 
array consisted of 39,556 non-control probes representing 37,687 genes. For Gas7 tg, Gpx3 
tg, Lactb tg, and Gyk female heterozygous ko, microarry profiling of the liver tissues was 
performed using Illumina MouseRef-8 beadchips. Each beadchip contained 24,886 
oligonucleotide probes (849 control and 24,837 non-control) designed based on the Mouse 
Exonic Evidence Based Oligonucleotide (MEEBO) set, the RIKEN FANTOM 2 database, 
and the NCBI Reference Sequence (RefSeq) database. Additional details can be found in the 
Supplementary Methods. All expression data have been submitted to GEO database under 
the Super-series accession number GSE12000.
Selection of active or expressed gene sets based on microarray profiling
As a limited number of mice (n=3–9) per mouse model was used for gene expression 
profiling and the statistical power was low considering the large number of multiple tests for 
tens of thousands genes, we restricted attention to the subsets of genes that are more 
biologically relevant. The Agilent arrays do not provide a measure of "presence" or 
"absence,” and therefore, we selected set of “most transcriptionally active genes” for mouse 
models profiled with Agilent arrays using the program Resolver 3,45,46. The active genes 
were defined as those with significance level p <0.05 (as determined by error model 3,45,46) 
in at least 10% animals for each strain of mice including both tg/ko and controls. These 
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active genes represent those whose expression levels vary across samples and, thus, are 
more biologically relevant. For mouse strains that were profiled with Illumina arrays, the 
program BeadArray was used to normalize the expression intensity values across as well as 
within arrays using the “average” algorithm embedded in the software. Genes with detection 
scores of >0.99 (corresponding to detection p<0.01) in at least 10% animals for each strain 
of mice were selected as "expressed" genes. This active/expressed gene selection procedure 
significantly reduced the size of starting gene sets for subsequent analysis from ~24,000 to 
~1000–9000 genes per strain of mice, thus helping to alleviate multiple testing concerns.
Selection of Signature gene sets based on microarray profiling
A Student’s t-test was used to identify genes with significant differences between tg or ko 
animals and the corresponding wt control mice. These genes were defined as “signature” 
genes, representing the perturbed gene expression signature as a result of single gene 
modification. The significance level was set to p<0.05. The false discovery rate at this 
significance level was calculated using Q-value as reported 47. All statistical analyses were 
carried out in the R statistical environment.
Pathway analysis
Each signature gene set identified above was classified using Gene Ontology (GO) 10 and 
Panther pathway 11 database assignments. The Ingenuity Pathway Analysis software 
(Ingenuity® Systems, www.ingenuity.com) was used to analyze the enrichment of canonical 
pathways in the signature genes identified above, and we also analyzed the enrichment of 
~470 functional gene sets curated from public databases using Gene Set Enrichment 
Analysis (GSEA) 12. Additional details can be found in the Supplementary Methods.
Mouse Crosses and Tissue Collection
Three mouse crosses constructed from C57BL/6J (B6), C3H/HeJ (C3H), and CAST/Ei 
(CAST), namely, B6 × C3H wildtype (BXH/wt), B6 × C3H on an ApoE null background 
(BXH/apoE), and B6 × CAST (BXC) were described previously 18,48. Additional details 
can be found in the Supplementary Methods. All procedures of housing and treatment of 
animals were performed in accordance with IACUC regulations.
Identification of the macrophage-enriched metabolic network (MEMN)
The construction of the coexpression network using liver and adipose tissues from BXH 
cross and the identification of the MEMN has been described previously 9. Briefly, both 
genotype and gene expression data were utilized to construct co-expression networks that 
consisted of highly connected genes from each tissue and sex. An iterative search algorithm 
was then used to detect highly interconnected subnetworks. One particular subnetwork that 
was highly enriched for causal genes for all metabolic traits tested, highly conserved 
between tissues and sexes, and highly enriched for macrophage genes was referred as 
MEMN.
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Construction of Bayesian network and subnetwork for candidate causal gene perturbation 
signatures
Liver expression data generated from the above three mouse cross populations BXH/wt, 
BXH/apoE, and BXC was integrated with the genotypic data also generated in the same 
populations to reconstruct the Bayesian networks as previously described 21–24. Additional 
details can be found in the Supplementary Methods.
The construction of a subnetwork for a set of signature genes in the network is as follows: 
given a set of genes, we identified all of the nearest neighbors of these genes in the network 
(i.e., we identified all nodes in the network that were either in the input set or directly 
connected to a node in the input set). This first step produced a set of node pairs connected 
by an edge. In the next step, direct connections/edges among all the nodes in these pairs 
were identified and added. The resulting largest connected subnetwork (i.e, all smaller 
subnetworks that disconnect from the largest connected subnetwork were removed) was 
used as the subnetwork to represent the input set of signature genes.
The core subnetwork was identified by searching for genes that were present in more than 
half, in this case, five of the subnetworks representing the nine liver signature gene sets of 
the mouse models. The enrichment of the core subnetwork for 2283 gene sets from Gene 
Ontology Biological Processes category was analyzed using Fisher's exact test. A statistical 
cutoff of 2.2e-5 was applied to the nominal p values to reflect the Bonferroni correction of 
multiple testing.
Comparison of signature genes across mouse models, between signature genes and the 
Bayesian subnetwork, and between signature genes and MEMN genes
The significance of overlap between different gene sets was estimated using Fisher's exact 
test statistics under the null hypothesis that the frequency of the genes in one signature set is 
the same between a reference set of 18,739 genes with Entrez Gene ID and the comparison 
gene set. The background for overlapping between gene sets and subnetworks in liver 
transcriptional network is 14,882 genes included in the whole network.
Enrichment of core subnetwork for genes/loci with low association p values to obesity 
traits in GWAS
The raw association p values between SNPs and body mass index (BMI) from the GWAS 
conducted by the BROAD Institute 31 were downloaded from the official website (http://
www.broad.mit.edu/diabetes/). For each gene in the 667 core subnetwork and the 102 mouse 
MEMN module 9 genes within the core subnetwork, SNPs within 100kb distance (50kb 
upstream and 50kb downstream), termed cis-SNPs, were selected from dbSNP database and 
their association p values to BMI in the control population of the BROAD GWAS study 
were extracted. We compared each set of cis-SNPs of interest with 105 sets of cis-SNPs 
from randomly selected gene sets with matched size on the human 44k array, such that the 
number of cis-SNPs from the random gene sets roughly matched that of the gene sets of our 
interest. Two different tests were used to estimate the significance of enrichment for low 
association p values as detailed in Supplementary Methods.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Adiposity (fat/muscle ratio) or body weight growth curves in the mouse models. The growth 
curves of males and females for each model are derived from the biweekly measurement of 
fat/muscle ratio every two weeks over the course of 14 weeks on a 6% fat diet. For Me1 ko, 
the growth curves are from weekly measurement of body weight over the course of 10 
weeks on a high fat diet. The p values are derived from the autoregressive model, which 
indicate the differences between the growth curves of tg/ko and wt, and are < 10−10 for 
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panels a, b, c, i, and j; < 10−5 for panels d and e; < 10−2 for panel g, and > 0.05 for panels f 
and h.
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Figure 2. 
Disruption of metabolic pathways involved in fat pad mass trait in mouse models of the 
candidate genes. The nine mouse models are labeled as 1 to 9 in red. Each of the metabolic 
pathways previously identified to be different between fat and lean mouse is marked with 
the identifiers of the mouse models whose liver gene expression signatures are enriched for 
the specific pathway. The number of pathways that are over-represented in the liver gene 
expression signature of each mouse model is listed in parenthesis following the name of 
each mouse model.
Yang et al. Page 18
Nat Genet. Author manuscript; available in PMC 2010 March 15.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 3. 
A portion of the core subnetwork, derived from the liver transcriptional subnetworks 
representative of gene expression signatures of the mouse models of the candidate genes. 
The liver transcriptional network is the union of Bayesian networks constructed from three 
crosses derived from B6, C3H, and CAST. This core subnetwork consists of key regulators 
for fatty acid and lipid metabolism, including Insig1 and Insig2 (in red), and is enriched for 
genes involved in related GO biological processes. A scalable image of the full subnetwork 
is included as Supplementary Figure 5.
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Table 5
Significant phenotypic traits observed in the mouse models.
Gene
symbol
Mouse
model
Sex Fat-related traits Lipid traits and glucose
Zfp90 tg M/F Increased fat/muscle growth, body weight,
total fat pad mass, total fat/body weight,
retroperitoneal fat pad, mesenteric fat pad,
subcutaneous fat pad
Gas7 tg M Decreased fat/muscle growth, body weight,
gonadal fat pad, total fat pad mass
Decreased total cholesterol, HDL, unesterified
choleseterol, triglyceride, and glucose
Gas7 tg F Decreased mesenteric fat pad mass Decreased unesterified cholesterol
Gpx3 tg M Decreased fat/muscle growth
Gpx3 tg F Decreased total cholesterol, HDL
Lactb tg M Increased fat/muscle growth
Lactb tg F Increased fat/muscle growth
Me1 ko M Decreased body weight
Me1 ko F Decreased body weight
Gyk ko F Increased free fatty acids, decreased glucose
Lpl ko
(het)
M Increased fat/muscle growth, total fat pad
mass, total fat/body weight, mesenteric fat
pad, subcutaneous fat pad
Increased triglycerides
Lpl ko
(het)
F Increased fat/muscle growth Increased triglycerides, decreased total
cholesterol and unesterified cholesterol
C3ar1 ko M Decreased fat/muscle growth
C3ar1 ko F Increased fat/muscle growth, gonadal fat
pad.subcutaneous fat pad
Tgfbr2 ko
(het)
M Decreased fat/muscle growth
Tgfbr2 ko
(het)
F Increased fat/muscle growth Increased free fatty acids
tg: transgenic; ko: knockout; het: heterozygote.
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